CorMatrix

Related by string. * * CorMatrix Cardiovascular . CorMatrix ECM *

Related by context. Frequent words. (Click for all words.) 61 Regado Biosciences 60 Amorcyte 59 Allograft 59 Galectin 3 58 Hemostasis 58 Pervasis 58 Seaside Therapeutics 58 ISHLT 57 Interventional Spine 57 MacuSight 57 DuraHeart 57 Anticoagulation 57 Cardiac Electrophysiology 57 Cardiovascular Imaging 56 Agios Pharmaceuticals 56 cartilage regeneration 56 Trophos 56 Edward Lanphier Sangamo 56 HepaLife Technologies Inc. 56 Source MDx 56 Eculizumab 56 InspireMD 56 CircuLite 55 Cylex 55 MDdatacor 55 Cardiometabolic 55 Receives Orphan Drug Designation 55 Wound Healing Society 55 #:#-# [001] 55 #-# Full Text 55 AOSSM 55 FASgen 55 Lung Transplantation 55 CVRx 55 Optimata 55 Gynecologic 55 CardiacAssist 55 Principle Investigator 55 Corventis 55 Immune Tolerance Network 55 Inovio Pharmaceuticals 55 Pivotal Trial 55 solid organ transplantation 55 FluoroPharma 54 AngioScore 54 CRVO 54 Pulmonary Rehabilitation 54 Nanotherapeutics 54 Cardiac Imaging 54 ViaCyte 54 Announces FDA Clearance 54 Viatronix 54 Medtronic Spinal 54 FzioMed 54 Cempra Pharmaceuticals 54 Carotid 54 Embolization 54 Ziosoft 54 Patient Registry 54 Autoimmunity 53 Celator Pharmaceuticals 53 InVivo Therapeutics 53 Mucosal 53 cardiac electrophysiology 53 Tissue Genesis 53 Romark 53 Pulmo BioTech Inc. 53 Metabolic Disorders 53 HydroCision 53 Genaera Corporation 53 Phase III Clinical Trial 53 ImmunoCellular Therapeutics 53 AxoGen 53 SonoPrep 53 Mayo Clinic Rochester MN 53 cardio renal 53 Pain Therapy 53 Autoimmune Disease 53 ARVO 53 NanoBio Corporation 53 MultiCell Technologies 53 Molecular Biometrics 53 INVO Bioscience 53 PARI Pharma 53 MAQUET Cardiovascular 53 Quark Pharmaceuticals 53 Clinical Pharmacy 53 Diagnostic Ultrasound 53 Vasomedical 52 Renal Solutions 52 Microvolt T Wave Alternans 52 InterCure 52 gastroenterological 52 Power3 Medical 52 Drug Shows Promise 52 AmpliMed 52 Neogenix Oncology 52 Stem Cell Innovations 52 multicenter prospective 52 Cellular Therapy 52 Surgical Treatment

Back to home page